COVID-19

COVID and the Microbiome

Research on the human microbiome has burgeoned in recent years. Microbiome imbalances have been linked to chronic conditions, such as diabetes, cardiovascular disease, and depression. But scientists have also uncovered evidence of the microbiome’s crucial role in infectious diseases, including COVID-19, pointing to it as a promising target for treating them. 

Overcoming Study-Patient Burdens in Medical Research During the Pandemic

Study-patient recruitment and retention continue to be significant challenges in medical research, and even more so, during the COVID-19 pandemic. The at-home isolation and social distancing orders for millions of Americans is a vital element to slow the COVID-19 pandemic, but the global pandemic has the potential to disrupt and delay vital research.

COVID-Sparked Practices Driving New Patient-Centric Behaviors

In 2000, Malcolm Gladwell’s The Tipping Point became a runaway bestseller by describing the factors that fuel an epidemic, and how the world suddenly becomes a different place as it reaches the inflection point. He discusses epidemics as spreading quickly like a virus, causing people to start behaving differently, triggering contagiousness, whether it applies to fashion trends, the uptake of cell phones, or the spread of disease.

Navigating the Pandemic: How will COVID-19 change R&D?

COVID-19 has put the biopharma industry into a tailspin – big pharma, biotech and small startups are all emerging in the development of a treatment and vaccine for this pandemic. Will COVID-19 change the current R&D landscape and create a new norm for the biopharma industry? Moderator: Joan Koerber-Walker President and CEO, Arizona BioIndustry Association (AZBio) Panelists: Brian Neman Co-Founder and CEO, Sanguine Todd Parsley Director of Preclinical Research, Infectious Diseases at Noble Life Sciences Inc Chris Moore, PhD Senior Director, Immunology, Arbutus Biopharma, Inc.

Recovered Coronavirus Patient Donates Blood To Help Vaccine, Treatment Research

WBZ | CBS Boston – Lara Woolfson’s COVID-19 story and her participation with Sanguine for her in-home blood sample collection. Transcript: Headline News: Live from the Channel 4 Studios in Boston, this is WBZ news at 5:30. Liam Martin: Well for a photographer from Boston who has already recovered from the coronavirus is hoping that her fight with it will help others recover as well.

PODCAST: The Bio Report: Bringing the Trial to the Patient

One of the challenges to securing the participation of patients in clinical trials can be simple geography. Sanguine Biosciences is seeking to tear down that barrier to participation by using mobile technology to bring clinical trials to patients. The company recently partnered with Vir Biotechnology to complete a COVID-19 clinical study aimed at better understanding the biology of the disease by sending healthcare personnel to collect blood samples from patients at their homes.

COVID-19: Navigating the Pandemic: COVID-19’s potential impact on the global pharmaceutical market?

  COVID-19 has spread to more than 60 countries, causing tens of thousands of illnesses and thousands of deaths. Pharma companies, biotechs, governments, academic institutions, nonprofits and others are all racing to develop a treatment, a cure and a vaccine. In this Sanguine Speaker Series (3) virtual fireside chat, we will discuss: Response efforts to the current COVID-19 pandemic How does the race for the cure affect the hundreds of other drugs in development COVID-19’s potential impact on the global pharmaceutical market?

COVID-19: Navigating the Pandemic: – How with COVID-19 effect research studies and clinical trials?

COVID-19 has spread to more than 60 countries, causing tens of thousands of illnesses and thousands of deaths. Pharma companies, biotechs, governments, academic institutions, nonprofits and others are all racing to develop a treatment, a cure and a vaccine. Moderator: Craig Lipset Independent Advisor, Former Head of Clinical Innovation, Pfizer Panelists: Brian Neman CEO and Co-Founder, Sanguine Lisa Tindell Vice President, Clinical Research Operations at Minneapolis Heart Institute Foundation Sal Salamone Editor in Chief, RTInsights.com Transcript John: We would like to welcome you to the Sanguine Speaker Series Webinar on COVID-19; Navigating the Pandemic.